EMCURE:NSE
Emcure Pharmaceuticals Ltd
₹2,348.90
arrow_downward
-0.54%(-12.80) 1D
Nov 16, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
₹2,350.00
High
₹2,389.80
Low
₹2,326.60
Mkt. cap
445.11B
Avg. vol.
228.06K
Volume
104.51K
Dividend
0.15%
Quarterly dividend
₹0.90
Ex-dividend date
Sep 4, 2026
P/E ratio
49.31
52-wk high
₹2,429.90
52-wk low
₹1,312.30
EPS
₹47.64
No. of employees
7K
Open
₹2,350.00
High
₹2,389.80
Low
₹2,326.60
Mkt. cap
445.11B
Avg. vol.
228.06K
Volume
104.51K
Dividend
0.15%
Quarterly dividend
₹0.90
Ex-dividend date
Sep 4, 2026
P/E ratio
49.31
52-wk high
₹2,429.90
52-wk low
₹1,312.30
EPS
₹47.64
No. of employees
7K
News stories
From web sources and news partners
Investing.com
·
2 minutes ago
Dow Jones, Nasdaq, S&P 500 weekly preview: Nvidia earnings, Anthropic IPO on deck
Barron's
·
29 minutes ago
S&P 500 Futures Fall in Premarket Trading; TELUS Corp., Vaxcyte Lead
Yahoo Finance
·
2 hours ago
A Tesla Merger Could Fast-Track SpaceX Into the S&P 500. Index Funds Would Have to Buy
The Motley Fool
·
36 minutes ago
If You Had Invested $10,000 in the Vanguard S&P 500 ETF (VOO) in 2016, Here's What You Would Have Today
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees6.91K
FoundedApr 16, 1981
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteemcure.com